Use of a compound in the manufacture of a medicament useful for the treatment by activation of the expression of the CIRP protein of a disease and composition (Machine-translation by Google Translate, not legally binding)

摘要

Use of a compound in the manufacture of a medicament useful for the treatment by activation of the expression of the CIRP protein of a disease and composition. Use of a compound in the manufacture of a medicament useful for the treatment by activation of the expression of the protein CIRP (heterogeneous ribonucleoprotein A18 [hnRNP A18]) of a disease of a homeothermic animal. Composition comprising the compound and use of the composition. (Machine-translation by Google Translate, not legally binding)